STAT3 and cancer: Little success has been obtained by blocking STAT3 directly since the difficulty of hunting an obviously druggable site from the STAT3.98 Although a number of small-molecule tool compounds for treating cancer in preclinical assays have been reported, all were hard to push their applications further due to micromolarpotencies and lack of specificity for STAT3 over other STAT proteins.